BMY
Bristol-Myers Squibb·NYSE
--
--(--)
--
--(--)
6.29 / 10
Outperform
Analyst consensus is neutral (2 analysts, 100% neutral). Fund‑flow score is 7.82/10 (good) with overall inflow ratio ~0.496 but negative trends across all size segments. Capital is flowing in despite price decline, indicating cautious optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-17
InstitutionHSBC
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of BMY?
- BMY holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.29/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
